Sponsor:
Pulmovant, Inc.
Code:
NCT07333183
Conditions
Pulmonary Hypertension
Interstitial Lung Disease (ILD)
Lung Diseases
Vascular Diseases
Cardiovascular Diseases
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
inhaled mosliciguat
Dry Powder Inhaler
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-23. This information was provided to ClinicalTrials.gov by Pulmovant, Inc. on 2026-01-12.